Pictet Asset Management (UK)’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-79,785
| Closed | -$1.89M | – | 878 |
|
|
2016
Q3 | $1.89M | Buy |
79,785
+4,100
| +5% | +$97.2K | 0.01% | 739 |
|
|
2016
Q2 | $2.59M | Sell |
75,685
-36,015
| -32% | -$1.23M | 0.01% | 708 |
|
|
2016
Q1 | $3.65M | Buy |
111,700
+2,600
| +2% | +$85K | 0.02% | 595 |
|
|
2015
Q4 | $4.67M | Buy |
109,100
+5,700
| +6% | +$244K | 0.02% | 564 |
|
|
2015
Q3 | $3.64M | Sell |
103,400
-9,200
| -8% | -$324K | 0.02% | 624 |
|
|
2015
Q2 | $5.46M | Buy |
+112,600
| New | +$5.46M | 0.02% | 567 |
|
|
2015
Q1 | – | Sell |
-13,800
| Closed | -$437K | – | 902 |
|
|
2014
Q4 | $437K | Hold |
13,800
| – | – | ﹤0.01% | 833 |
|
|
2014
Q3 | $327K | Sell |
13,800
-198,400
| -93% | -$4.7M | ﹤0.01% | 831 |
|
|
2014
Q2 | $6.36M | Buy |
212,200
+46,300
| +28% | +$1.39M | 0.03% | 487 |
|
|
2014
Q1 | $4.38M | Buy |
165,900
+6,300
| +4% | +$166K | 0.02% | 565 |
|
|
2013
Q4 | $4.01M | Sell |
159,600
-78,600
| -33% | -$1.98M | 0.02% | 575 |
|
|
2013
Q3 | $4.89M | Sell |
238,200
-120,800
| -34% | -$2.48M | 0.03% | 513 |
|
|
2013
Q2 | $7.16M | Buy |
+359,000
| New | +$7.16M | 0.04% | 395 |
|